Press Releases

Date Title and Summary Additional Formats
11/19/13 Phibro Animal Health Corporation and Epitopix, LLC form Poultry Vaccine Partnership
Phibro Animal Health Corporation and Epitopix, LLC form Poultry Vaccine Partnership Teaneck, NJ and Willmar, MN – November 19, 2013 Phibro Animal Health Corporation and Epitopix have entered into a partnership to manufacture and market biological products for chickens in the United States based on
View HTML
07/05/17 Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro's Poultry Vaccine Technologies
TEL AVIV, Israel and AHMEDABAD, India, July 05, 2017 (GLOBE NEWSWIRE) -- (NASDAQ:PAHC) Phibro Animal Health Corporation and Zydus Cadila today announced their intention to enter into a long-term arrangement to license Phibro's innovative poultry vaccine technologies and know-how to a new vaccine
View HTML
01/25/16 Phibro Animal Health Corporation Announces Closing of Acquisition of Business of MVP Laboratories, Inc.
TEANECK, N.J., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation ("Phibro") (NASDAQ:PAHC) today announced it has completed its purchase of the assets of MVP Laboratories, Inc. ("MVP"), a developer, manufacturer and marketer of livestock vaccines, vaccine adjuvants and other
View HTML
01/22/15 Phibro Animal Health Corporation Announces Entry Into Collaboration Agreement, License Agreement and Intellectual Property Acquisition Agreement
TEANECK, N.J. , Jan. 22, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation ("Phibro") (Nasdaq:PAHC) today announced it has acquired exclusive North American distribution rights for vaccines using MJ Biologicals, Inc.'s ("MJB") vaccine technologies focused on the swine industry and
View HTML
05/31/16 Phibro Animal Health Corporation Announces Gerald Carlson Retirement, Larry Miller Promotion
TEANECK, N.J., May 31, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced that Gerald Carlson, Chief Operating Officer, will retire after 14 years with Phibro, effective July 1, 2016.  Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer
View HTML
01/20/14 Phibro Animal Health Corporation announces its Phibro Aquaculture Business Unit, led by Dr. Ra’anan Ariav, and the Acquisition of the Assets of AquaVet Ltd.
Phibro Animal Health Corporation announces its Phibro Aquaculture Business Unit, led by Dr. Ra’anan Ariav, and the Acquisition of the Assets of AquaVet Ltd. Teaneck, NJ – January 20, 2014 Phibro Animal Health Corporation announced today that it has acquired the aquaculture assets of AquaVet Ltd., a
View HTML
03/31/14 Phibro Animal Health Corporation Announces Launch of Initial Public Offering
Phibro Animal Health Corporation Announces Launch of Initial Public Offering Phibro Animal Health Corporation Announces Launch of Initial Public Offering Teaneck, New Jersey, March 31, 2014 – Phibro Animal Health Corporation (the “Company”) today announced that it has commenced an initial public
View HTML
01/26/15 Phibro Animal Health Corporation Announces Licensing Agreement With Merial for Phibro's Vaccine Delivery Technology
TEANECK, N.J. , Jan. 26, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq:PAHC) today announced it has entered into a long-term global license arrangement with Merial SAS ( Lyon, France ) to share in the use of Phibro's vaccine delivery technology for use in animal vaccines.
View HTML
05/11/15 Phibro Animal Health Corporation Announces the Appointment of Dr. George Gunn to Its Board of Directors and Declares Quarterly Dividend
TEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr.
View HTML
05/09/16 Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J. , May 09, 2016 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on June 22, 2016 , to stockholders of record at the
View HTML